• Patent Title: Dermatitis treatment
  • Application No.: US16117148
    Application Date: 2018-08-30
  • Publication No.: US10758499B2
    Publication Date: 2020-09-01
  • Inventor: Berit Johansen
  • Applicant: Avexxin AS
  • Applicant Address: NO Trondheim
  • Assignee: Avexxin AS
  • Current Assignee: Avexxin AS
  • Current Assignee Address: NO Trondheim
  • Agency: McCarter & English, LLP
  • Agent Steven G. Davis
  • Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@65195609
  • Main IPC: A61K31/121
  • IPC: A61K31/121
Dermatitis treatment
Abstract:
A compound of formula (I) R-L-CO—X  (I) (wherein R is a C10-24 unsaturated hydrocarbon group optionally interrupted by one or more heteroatoms or groups of heteroatoms selected from S, O, N, SO, SO2, said hydrocarbon group comprising at least 4 non-conjugated double bonds; L is a linking group forming a bridge of 1 to 5 atoms between the R group and the carbonyl CO wherein L comprises at least one heteroatom in the backbone of the linking group; and X is an electron withdrawing group) or a salt thereof for use in the treatment of dermatitis.
Public/Granted literature
Information query
Patent Agency Ranking
0/0